Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Executive Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Trofinetide Published Studies & Presentations
Rett Syndrome
NNZ-2591Published Studies & Presentations
Phelan-McDermid Syndrome
Pitt Hopkins Syndrome
Angelman Syndrome
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
Investor Presentations
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
Investor Presentations
Filter by Year:
2025
2024
2023
2022
2021
18-Dec-2023
Investor web conference, 18 December 2023
18-Dec-2023
Investor presentation, 18 December 2023
8-Nov-2023
Investor presentation, 8 November 2023
29-Aug-2023
Investor web conference, 28 August 2023
28-Aug-2023
Investor presentation, 28 August 2023
14-Jul-2023
Investor web conference, 14 July 2023
5-Jun-2023
Jefferies Global Healthcare Conference, 8 June 2023
2-Jun-2023
AGM webcast, 30 May 2023
30-May-2023
AGM Chair Address & CEO Presentation
17-Mar-2023
Investor webinar, 14 March 2023
1